We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.88B
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
+13.85%
1 Year Est. Return
+32.38%
3 Year Est. Return
+99.93%
5 Year Est. Return
+115.9%
10 Year Est. Return
+395.31%
AUM
$1.14B
AUM Growth
+$97.6M
Cap. Flow
-$16.4M
Cap. Flow %
-1.44%
Top 10 Hldgs %
20.55%
Holding
1,047
New
117
Increased
379
Reduced
323
Closed
176
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMDA
1001
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
-17,715
Closed -$74K
GERM
1002
DELISTED
Amplify Treatments, Testing and Advancements ETF
GERM
-13,924
Closed -$385K
ARAV
1003
DELISTED
Aravive, Inc. Common Stock
ARAV
-22,100
Closed -$104K
AEY
1004
DELISTED
ADDvantage Technologies Group
AEY
-5,863
Closed -$113K
ICPT
1005
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-6,611
Closed -$274K
ZYNE
1006
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-11,900
Closed -$39K
PRTK
1007
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-45,369
Closed -$245K
HARP
1008
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
-1,382
Closed -$235K
ISEE
1009
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-11,000
Closed -$62K
NYMX
1010
DELISTED
Nymox Pharmaceutical Corp
NYMX
-19,100
Closed -$47K
INDT
1011
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
-4,148
Closed -$222K
UNAM
1012
DELISTED
Unico American Corp
UNAM
-20,132
Closed -$104K
ACOR
1013
DELISTED
Acorda Therapeutics
ACOR
-126
Closed -$8K
APTX
1014
DELISTED
Aptinyx Inc. Common Stock
APTX
-16,200
Closed -$55K
IMV
1015
DELISTED
IMV Inc. Common Shares
IMV
-1,160
Closed -$52K
NVCN
1016
DELISTED
Neovasc Inc.
NVCN
-1,234
Closed -$66K
PHAS
1017
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
-13,865
Closed -$49K
AMPE
1018
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-220
Closed -$63K
CHNG
1019
DELISTED
Change Healthcare Inc. Common Stock
CHNG
-14,380
Closed -$209K
ALNA
1020
DELISTED
Allena Pharmaceuticals
ALNA
-24,150
Closed -$36K
ATHX
1021
DELISTED
Athersys, Inc. Common Stock
ATHX
-888
Closed -$43K
EPZM
1022
DELISTED
Epizyme, Inc
EPZM
-26,450
Closed -$316K
MBII
1023
DELISTED
Marrone Bio Innovations, Inc.
MBII
-37,129
Closed -$45K
CALA
1024
DELISTED
Calithera Biosciences, Inc
CALA
-1,025
Closed -$71K
MCA
1025
DELISTED
BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC
MCA
-11,523
Closed -$165K

Similar funds

Wedbush Securities's Q4 2020 Portfolio in Review

As of Q4 2020, Wedbush Securities held 1,047 positions worth $1.14B, up 9.4% from $1.04B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Wedbush Securities's Q4 2020 filing shows 117 new, 379 increased, 323 reduced and 176 closed positions. Its largest new stake was Cohen & Steers Tax-Advantaged Preferred Securities & Income Fund: 284,367 shares worth $7.39M. The largest sale was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $5.76M.

By sector, the portfolio is most concentrated in Miscellaneous at 32% of assets, down from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Wedbush Securities's largest Q4 2020 buy was Cohen & Steers Tax-Advantaged Preferred Securities & Income Fund: 284,367 shares worth $7.39M.
  • Wedbush Securities added most to Microsoft in Q4 2020, an estimated $2.09M increase.
  • Wedbush Securities's biggest Q4 2020 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $5.76M.
  • Wedbush Securities fully exited First Trust Large Cap Growth AlphaDEX Fund in Q4 2020, selling an estimated $3.82M.
  • Wedbush Securities's ten largest holdings make up 21% of its $1.14B portfolio in Q4 2020.
  • Wedbush Securities opened 117 new positions and closed 176 in Q4 2020.
  • Wedbush Securities's portfolio value rose 9.4% quarter-over-quarter to $1.14B.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.